Saturday, August 18, 2018
 
 
Company News: Page (1) of 1 - 06/02/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
An Evening with Temple Grandin: Connecting Animal Behavior & Autism - August 2, 2018

(June 02, 2018)

Seattle, WA, June 02, 2018 --(PR.com)-- Come spend an Evening with Dr. Temple Grandin, professor of animal science at Colorado State University, consultant to the livestock industry on animal behavior, and autism spokesperson. She is one of the first individuals on the autism spectrum to publicly share insights from her personal experience of autism and its relation to animals.



Dr. Grandin will discuss autism and its advantage in working with animals. Whether you are a member of the autism community or the livestock arena, you will find this talk informative and unforgettable.



“Autism helped me understand animals because I think in pictures. Since animals do not have language, their memories have to be sensory-based instead of word-based.” - Dr. Temple Grandin

About the Venue:
Benaroya Hall
S. Mark Taper Foundation Auditorium
200 University Street
Seattle, WA 98101

Contact Information:
Future Horizons, Inc.
Rebecca Kanney
817.277.0727
Contact via Email
http://fhautism.com/

Read the full story here: https://www.pr.com/press-release/755496

Press Release Distributed by PR.com

Copyright PR.com


Page: 1


Related Keywords:Business,Awards,Women in Business,Education,College & University,Medical & Health,Infectious Diseases,ResearchBusiness,Awards,Diversity & Society,Disability,Education,College & University,Trade & SpecialtyBusiness,Trade Shows & EventsDiversity & Society
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines